Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study

PURPOSE: The goal of this study was to evaluate the safety and effectiveness of lurasidone among patients with schizophrenia in a 12-week open-label extension study. PATIENTS AND METHODS: Patients who completed a 6-week, double-blind, placebo-controlled study were enrolled in a 12-week open-label ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Iyo, Masaomi, Ishigooka, Jun, Nakamura, Masatoshi, Sakaguchi, Reiko, Okamoto, Keisuke, Mao, Yongcai, Tsai, Joyce, Fitzgerald, Alison, Takai, Kentaro, Higuchi, Teruhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379682/
https://www.ncbi.nlm.nih.gov/pubmed/34429604
http://dx.doi.org/10.2147/NDT.S320021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8379682/
https://www.ncbi.nlm.nih.gov/pubmed/34429604
http://dx.doi.org/10.2147/NDT.S320021

Ejemplares similares